Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Morphine sulfate 10mg/5ml oral solution
0407020Q0AACNCN
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 208,686 |
|
Oramorph 10mg/5ml oral solution
0407020Q0BCAGCN
|
Oramorph | Morphine sulfate | Central Nervous System | 131,651 |
|
Zomorph 10mg modified-release capsules
0407020Q0BKAAEF
|
Zomorph | Morphine sulfate | Central Nervous System | 105,887 |
|
Zomorph 30mg modified-release capsules
0407020Q0BKABEG
|
Zomorph | Morphine sulfate | Central Nervous System | 86,769 |
|
Morphine sulfate 10mg/1ml solution for injection ampoules
0407020Q0AAABAB
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 61,057 |
|
MST Continus 10mg tablets
0407020Q0BBAAAK
|
MST Continus | Morphine sulfate | Central Nervous System | 32,381 |
|
Zomorph 60mg modified-release capsules
0407020Q0BKACEH
|
Zomorph | Morphine sulfate | Central Nervous System | 30,371 |
|
MST Continus 5mg tablets
0407020Q0BBAKCG
|
MST Continus | Morphine sulfate | Central Nervous System | 29,467 |
|
Morphine 10mg modified-release capsules
0407020Q0AAEFEF
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 27,809 |
|
Morphine 5mg modified-release tablets
0407020Q0AACGCG
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 25,980 |
|
Morphine 10mg modified-release tablets
0407020Q0AAAKAK
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 24,097 |
|
MST Continus 30mg tablets
0407020Q0BBABAL
|
MST Continus | Morphine sulfate | Central Nervous System | 19,795 |
|
Morphine 30mg modified-release capsules
0407020Q0AAEGEG
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 16,638 |
|
MST Continus 15mg tablets
0407020Q0BBALCF
|
MST Continus | Morphine sulfate | Central Nervous System | 16,202 |
|
Sevredol 10mg tablets
0407020Q0BHACCD
|
Sevredol | Morphine sulfate | Central Nervous System | 14,883 |
|
Morphine 10mg tablets
0407020Q0AACDCD
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 14,218 |
|
Morphine 30mg modified-release tablets
0407020Q0AAALAL
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 13,074 |
|
Morphine 15mg modified-release tablets
0407020Q0AACFCF
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 12,696 |
|
Zomorph 100mg modified-release capsules
0407020Q0BKADEB
|
Zomorph | Morphine sulfate | Central Nervous System | 8,089 |
|
MST Continus 60mg tablets
0407020Q0BBACAI
|
MST Continus | Morphine sulfate | Central Nervous System | 7,691 |
|
Morphgesic SR 10mg tablets
0407020Q0BNAAAK
|
Morphgesic | Morphine sulfate | Central Nervous System | 5,019 |
|
Sevredol 20mg tablets
0407020Q0BHADCE
|
Sevredol | Morphine sulfate | Central Nervous System | 4,320 |
|
Morphine 60mg modified-release capsules
0407020Q0AAEHEH
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 4,140 |
|
Morphine 20mg tablets
0407020Q0AACECE
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 3,766 |
|
Morphgesic SR 30mg tablets
0407020Q0BNABAL
|
Morphgesic | Morphine sulfate | Central Nervous System | 3,761 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.